Groundbreaking
scientific discoveries
that are about to
change the world.
Portfolio Companies
Alabama’s Top Rated Pediatric Urgent Care
Urgent Care for Children (UC4C) was founded by a group of physicians who, as parents themselves, understood that children’s illnesses or injuries don’t follow normal business hours. Their on-site pediatricians and pediatric nurse practitioners offer acute diagnostic and treatment care for children with non-life-threatening needs during the day, after-hours and on weekends, 365 days a year.
In 2017, UC4C opened its first clinic in Birmingham, Alabama with a mission to provide quality care with less waiting. Today, UC4C operates eleven clinics across the Southeast in addition to a telemedicine portal that brings our clinic to you.
Probiotic Nutritional Supplements for Lung Health
ResBiotic is a team of scientists, physicians, and innovators pioneering microbiome-based nutritional products for lung health.
Founded in 2020 by Dr. C Vivek Lal MD FAAP, the company is rooted in over a decade of research at the intersection of human microbiome science and respiratory health. They partner with leading research organizations to develop and test proprietary probiotic strains to support lung health independently, as a blend, and in combination with bioactive botanicals.
ResBiotic’s first product, resB® Lung Support, is a dietary supplement that targets the gut-lung axis to support lung health.
Disruptive Therapeutics
for Respiratory Disease
Alveolus Bio is a team of scientists, physicians, and innovators pioneering disruptive therapeutics for the prevention and treatment of lung disease.
Respiratory health risks and lung diseases are associated with lung dysbiosis – also known as an abnormal lung microbiome. An abnormal microbiome induces further inflammation, creating a downward spiral.
Alveolus’s pipeline includes live biotherapeutics and other pharmaceutical interventions that target microbiome-based pathways to alter the course of respiratory diseases.